XBiotech Inc. (XBIT) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 150 transactions totaling $65.9M, demonstrating a bearish sentiment with -$41.5M in net insider flow. The most recent transaction on Dec 16, 2021 involved a transaction of 250,000 shares valued at $2.5M.
No significant insider buying has been recorded for XBIT in the recent period.
No significant insider selling has been recorded for XBIT in the recent period.
Based on recent SEC filings, insider sentiment for XBIT is bearish with an Insider Alignment Score of 18/100 and a net flow of -$41.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at XBiotech Inc. (XBIT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading XBIT stock, having executed 150 transactions in the past 90 days. The most active insider is Thomas Gut (Executive), who has made 3 transactions totaling $173.0M.
Get notified when executives and directors at XBIT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 16, 2021 | Thorpe Mckenzie W. | Executive | Option Exercise | 250,000 | $10.00 | $2.5M | Large |
| Dec 16, 2021 | Thorpe Mckenzie W. | Executive | Payment | 213,493 | $11.71 | $2.5M | Large |
| Oct 18, 2021 | Simard John | Executive | Sale | 33,000 | $13.07 | $431.3K | |
| Oct 15, 2021 | Simard John | Executive | Sale | 17,000 | $13.32 | $226.4K | |
| Oct 14, 2021 | Simard John | Executive | Sale | 21,125 | $12.90 | $272.5K | |
| Oct 13, 2021 | Simard John | Executive | Sale | 10,875 | $12.83 | $139.5K | |
| Oct 12, 2021 | Simard John | Executive | Sale | 18,000 | $12.77 | $229.9K | |
| Oct 7, 2021 | Simard John | Executive | Sale | 39,286 | $12.45 | $489.1K | |
| Oct 6, 2021 | Simard John | Executive | Sale | 10,714 | $12.53 | $134.2K | |
| Oct 5, 2021 | Simard John | Executive | Sale | 14,218 | $12.66 | $180.0K | |
| Oct 4, 2021 | Simard John | Executive | Sale | 23,681 | $13.08 | $309.7K | |
| Oct 1, 2021 | Simard John | Executive | Sale | 19,684 | $13.23 | $260.4K | |
| Sep 30, 2021 | Simard John | Executive | Sale | 18,558 | $13.07 | $242.6K | |
| Sep 29, 2021 | Simard John | Executive | Sale | 16,396 | $13.41 | $219.9K | |
| Sep 28, 2021 | Simard John | Executive | Sale | 6,263 | $14.27 | $89.4K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Disposition(D) | 15 | $391.5M | 81.6% |
Sale(S) | 69 | $53.7M | 11.2% |
Purchase(P) | 25 | $12.2M | 2.5% |
Other(O) | 2 | $10.0M | 2.1% |
Exercise(M) | 32 | $9.2M | 1.9% |
Payment(F) | 2 | $3.4M | 0.7% |
Other(J) | 1 | $0 | 0.0% |
Gift(G) | 4 | $0 | 0.0% |
Insider selling pressure at XBiotech Inc. has increased, with 11 insiders executing 150 transactions across all time. Total sales of $53.7M significantly outpace purchases of $12.2M, resulting in a net outflow of $41.5M. This selling activity appears largely discretionary, which may warrant closer attention from investors.